These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1875287)

  • 1. Application of a linear recirculation model to drug targeting.
    Boddy AV; Aarons LJ
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):355-62. PubMed ID: 1875287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of drug targeting: steady-state considerations using a three-compartment model.
    Boddy A; Aarons L; Petrak K
    Pharm Res; 1989 May; 6(5):367-72. PubMed ID: 2748526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison and critique of two models for regional drug delivery.
    Siegel RA; MacGregor RD; Hunt CA
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):363-73; discussion 373-4. PubMed ID: 1875288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the possibility of the second peak of drug plasma concentration time curve after iv bolus administration from the standpoint of the traditional multi-compartmental linear pharmacokinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2008 Jun; 97(6):2385-93. PubMed ID: 17828740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY; Jusko WJ
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fit fluctuating blood drug concentration: a beginner's first note.
    Wu G
    Pharmacol Res; 1996 Jun; 33(6):379-83. PubMed ID: 8971962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [General expression of linear pharmacokinetic model].
    Liu D; Li J; Liu X
    Hua Xi Yi Ke Da Xue Xue Bao; 1994 Sep; 25(3):305-11. PubMed ID: 7896250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamical dosage regimen calculations in linear pharmacokinetics.
    Iliadis A; Bruno R; Cano JP
    Comput Biomed Res; 1988 Jun; 21(3):203-20. PubMed ID: 3383552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic considerations of regional administration and drug targeting: influence of site of input in target tissue and flux of binding protein.
    Rowland M; McLachlan A
    J Pharmacokinet Biopharm; 1996 Aug; 24(4):369-87. PubMed ID: 9044166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A general model of metabolite kinetics following intravenous and oral administration of the parent drug.
    Weiss M
    Biopharm Drug Dispos; 1988; 9(2):159-76. PubMed ID: 3370305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of apparent systemic clearance to individual organ clearances: effect of pulmonary clearance and site of drug administration and measurement.
    Mehvar R
    Pharm Res; 1991 Mar; 8(3):306-12. PubMed ID: 2052516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some considerations on the design of population pharmacokinetic studies.
    Duffull S; Waterhouse T; Eccleston J
    J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):441-57. PubMed ID: 16284917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.
    Wu X; Nekka F; Li J
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):447-59. PubMed ID: 27405818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.
    Vaughan
    Eur J Clin Pharmacol; 1977; 11(1):57-64. PubMed ID: 832659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of pharmaceutical preparations by extra-label routes: special considerations and potential pitfalls.
    Jenkins WL; Friedlander LG
    J Am Vet Med Assoc; 1988 Jan; 192(2):256-61. PubMed ID: 3280537
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcellular drug targeting, pharmacokinetics and bioavailability.
    Leucuta SE
    J Drug Target; 2014 Feb; 22(2):95-115. PubMed ID: 24188545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled-delivery drugs].
    Rubio Lotvin B
    Rev Alerg Mex; 1997; 44(1):31-4. PubMed ID: 9221101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic requirements for successful site-directed targeting of drugs.
    McMartin C
    Biotherapy; 1991; 3(1):9-23. PubMed ID: 2009218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.